Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2026-03-01 @ 6:02 AM
Study NCT ID:
NCT02943668
Status:
TERMINATED
Last Update Posted:
2020-07-01
First Post:
2016-10-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-21
First Submit QC Date:
None
Study First Post Date:
2016-10-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-12
Results First Submit QC Date:
None
Results First Post Date:
2020-07-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-04-28
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-06-12
Last Update Post Date:
2020-07-01
Last Update Post Date Type:
ACTUAL